Drug Discovery · New Haven, CT · Founded 2018 · Privately Held (backing)
Developer of a drug discovery platform designed to create therapeutic and precision medicines. Halda Therapeutics is based in New Haven, CT and was founded in 2018. Its last known valuation is $3 billion. It has raised $227 million across 3 recorded rounds; the latest was a $126 million Series B in Jul 2024.
Last price · $/share
—
Implied valuation
$3.0B
Total raised
$227.1M
Last round
Later Stage VC (Series B)
Jul 2024
Cap table — not yet on record
Halda Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Halda Therapeutics with a free account
·The complete investor list: 14 names
·Watch Halda Therapeutics: the Monday email on marks, rounds and moves
Where does Halda Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Halda Therapeutics's 3 recorded funding rounds.